CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $492,377 | -46.7% | 78,529 | -70.2% | 0.04% | -59.6% |
Q3 2022 | $923,000 | +18.6% | 263,529 | 0.0% | 0.10% | -8.3% |
Q2 2022 | $778,000 | -5.0% | 263,529 | 0.0% | 0.11% | +52.1% |
Q1 2022 | $819,000 | -8.0% | 263,529 | 0.0% | 0.07% | +39.2% |
Q4 2021 | $890,000 | -7.5% | 263,529 | 0.0% | 0.05% | +4.1% |
Q3 2021 | $962,000 | -16.3% | 263,529 | 0.0% | 0.05% | -27.9% |
Q2 2021 | $1,149,000 | -4.0% | 263,529 | 0.0% | 0.07% | -27.7% |
Q1 2021 | $1,197,000 | -20.9% | 263,529 | 0.0% | 0.09% | -5.1% |
Q4 2020 | $1,513,000 | -20.7% | 263,529 | 0.0% | 0.10% | -41.1% |
Q3 2020 | $1,908,000 | +107.4% | 263,529 | 0.0% | 0.17% | +90.9% |
Q2 2020 | $920,000 | -1.7% | 263,529 | -58.3% | 0.09% | -3.3% |
Q1 2020 | $936,000 | -37.8% | 632,387 | -17.7% | 0.09% | -27.2% |
Q4 2019 | $1,506,000 | -61.7% | 768,142 | 0.0% | 0.12% | -71.3% |
Q3 2019 | $3,933,000 | -33.7% | 768,142 | -7.9% | 0.44% | +11.2% |
Q2 2019 | $5,935,000 | -43.4% | 834,096 | +5.3% | 0.39% | -41.1% |
Q1 2019 | $10,485,000 | +69.1% | 792,096 | 0.0% | 0.67% | +80.0% |
Q4 2018 | $6,199,000 | +20.4% | 792,096 | +70.8% | 0.37% | +49.8% |
Q3 2018 | $5,147,000 | – | 463,807 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |